Keyword: SARS-CoV-2
COVID-19
ButanVac clinical trials begin
ButanVac, the vaccine candidate that will be produced by the Butantan Institute entirely in Brazil with no need to import any ingredients, has begun clinical trials
By Redação
COVID-19
Life expectancy falls in Brazil
The high mortality rate has reduced the population's life expectancy
By Redação
COVID-19
2.3 billion people without soap and water
Some 2.3 billion people, equivalent to 30% of the world's population, had no water, soap, or either in 2020
By Redação
Data
Scientific research on coronaviruses: the impact of COVID-19
Scientific research on coronaviruses: the impact of COVID-19
By Redação
COVID-19
Warning from the deep
Monitoring the novel coronavirus in sewage systems improves epidemiological surveillance in Brazilian cities
By Tiago Jokura
COVID-19
The awakening of a dormant virus
Study suggests that SARS-CoV-2 activates dormant virus in the human genome
By Redação
COVID-19
Hybrid coronavirus antibodies
A promising strategy for preventing and treating the novel coronavirus has been successfully tested in mice by researchers at the University of Texas Health Science Center at Houston, USA
By Redação
COVID-19
Changes in alcohol consumption
Self isolation and social distancing seem to be changing the way alcohol is consumed in Latin America and the Caribbean, with a fall in the number of people drinking
By Redação
COVID-19
Birth rates fall in six state capitals
The number of new births has dropped further in six Brazilian capitals during the pandemic
By Redação
COVID-19
Deaths exacerbate income losses
Death of 430,000 people from COVID-19 until May could cost the economy R$10.9 billion per month
By Redação
COVID-19
Risk of death is higher among the poor in Chile
People under 40 living in poorer municipalities in the Metropolitan Region of Santiago, Chile, are 3.1 times more likely to die from complications associated with COVID-19 than those who live in more affluent regions
By Redação
COVID-19
Lasting consequences
People who survive SARS-CoV-2, even those not hospitalized, can suffer the effects of the infection for months after the most intense symptoms subside
By Redação
COVID-19
The virus and the loss of smell
The loss of smell that affects up to two-thirds of people infected with SARS-CoV-2 is a consequence of both the direct action of the virus and the inflammation it triggers in the olfactory system, according to a team of researchers
By Redação
COVID-19
Dengue increases risk of COVID-19 symptoms
The risk of developing COVID-19 symptoms when infected with the novel coronavirus is twice as high among individuals who have had dengue in the past
By Redação
Covid-19
Mask effectiveness tests
Researchers compared the quality of 227 types of face masks sold in Brazil, measuring their ability to block the novel coronavirus
By Redação
COVID-19
New clues about blood clots linked to the AstraZeneca vaccine
A step has been taken towards explaining why the vaccine developed by the pharmaceutical company AstraZeneca can very rarely lead to the formation of blood clots
By Redação
COVID-19
The months-long consequences of COVID-19
The long-term effects of COVID-19 are becoming clearer
By Redação
COVID-19
The importance of the cellular response against the coronavirus
Fighting a SARS-CoV-2 infection is not solely the responsibility of antibodies, the proteins that adhere to the virus’s surface to prevent it from entering cells or mark it for destruction
By Redação
COVID-19
Two vaccines prevent infection by Sars-CoV-2
Pfizer-BioNTech and Moderna vaccines are 80% effective at preventing SARS-Cov-2 infections after the first dose and 90% after the second
By Redação